Health insurers are expressing measured optimism for enrollment in the coverage they're selling on the health insurance exchanges after quietly grumbling for weeks that the fumbled rollout was undermining their business plans.
Health insurers are expressing measured optimism for enrollment in the coverage they're selling on the health insurance exchanges after quietly grumbling for weeks that the fumbled rollout was undermining their business plans.
Some health insurance executives expressed some modest bullishness on the exchanges Tuesday at the JP Morgan Healthcare conference in San Francisco, even though a day earlier HHS revealed that the enrollees so far are skewing older than many had hoped.
WellPoint President and CEO Joseph Swedish said he expects exchange enrollment to accelerate as people gain more familiarity with the plans and the potential subsidies available, and as a larger number of employers begin to gradually shift employees to the marketplaces.
Read the full story here: http://bit.ly/1dyvl5Q
Source: Modern Healthcare
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Bustling Gene Therapy Pipeline for Neuromuscular Diseases Brings Thorny Questions to the Clinic
March 18th 2025The rapid development of gene therapy options for treating neuromuscular diseases has created new therapeutic options but also logistical hurdles and a need for complex discussions between clinicians and families.
Read More